LKFT · Lakefront Biotherapeutics NV
$27.53
-0.51 (-1.82%)
At close · Aug 14
Market Cap
$1.80B
Shares
65.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$27.53
Open$27.72
Day$27.47–27.80
52W close$26.08–37.62
Avg vol 30d207K
Short int2.5M · 3.9% float · 14.1d
Short vol75%
Last earningsMay 7, 2026
DataJan 2020–Aug 2026
Up next
Next earnings call
Sep 11, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−10%
below
Price vs 50-day avg
−4%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
13%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−19%
trailing
YTD return
−16%
this year
Relative strength
−32%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $29 › 200d $31 — 200d above 50d
Institutional flow
Distributing
-13% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.85% of float · ▲ +8.6% MoM · 14.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
78 holders — mid 3-yr range
Squeeze score
72
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
2.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−10%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $29 › 200d $31 — 200d above 50d
Institutional flow
Distributing
-13% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.85% of float · ▲ +8.6% MoM · 14.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
78 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $26
Now $28 · 13%
Range high $38
vs 200-day avg -10%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LKFT
this stock
Lakefront Biotherapeutics NV
|
$1.80B | -15.8% | — | — | 3.9% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LKFT | +2.0% | -8.3% | -18.7% | +1.2% | -15.8% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +1.6% | -12.7% | -32.5% | -2.7% | -29.7% |
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
80 filings
77 filers
Visit website
Investor relations